JJ

Johannes Jacob Pieter Kastelein

DELAYED 1 MONTH

Director, Chief Scientific Officer

NewAmsterdam Pharma Co N.V.

Filings

1

Companies

1

Latest

Mar 5, 2026

Transactions

Signal

Ticker / Company

Insider

Transaction

Value

Filed

70
NAMS81% OUT

NewAmsterdam Pharma Co N.V.

Johannes Jacob Pieter Kastelein

Director, Chief Scientific Officer

Sale

$3.1M

101,409 sh

Mar 10 12:18 AM

Mar 9, 2026

—

NewAmsterdam Pharma Co N.V.

Johannes Jacob Pieter Kastelein

Director, Chief Scientific Officer

Option Exercise

—

101,409 sh

Mar 10 12:18 AM

Mar 9, 2026

70
NAMS81% OUT

NewAmsterdam Pharma Co N.V.

Johannes Jacob Pieter Kastelein

Director, Chief Scientific Officer

Sale

$2.9M

94,124 sh

Mar 10 12:18 AM

Mar 6, 2026

—

NewAmsterdam Pharma Co N.V.

Johannes Jacob Pieter Kastelein

Director, Chief Scientific Officer

Option Exercise

—

94,124 sh

Mar 10 12:18 AM

Mar 6, 2026

70
NAMS81% OUT

NewAmsterdam Pharma Co N.V.

Johannes Jacob Pieter Kastelein

Director, Chief Scientific Officer

Sale

$3.2M

104,467 sh

Mar 10 12:18 AM

Mar 5, 2026

—

NewAmsterdam Pharma Co N.V.

Johannes Jacob Pieter Kastelein

Director, Chief Scientific Officer

Option Exercise

—

104,467 sh

Mar 10 12:18 AM

Mar 5, 2026